Skip to main content
. 2023 Nov 15;15:200. doi: 10.1186/s13195-023-01344-0

Fig. 3.

Fig. 3

EQ-5D utility trajectory in amyloid-negative (A −) and amyloid-positive (A +) patients, linear-mixed effect model with three-way interaction of clinical stage × time × amyloid status, model adjusted for baseline age, sex, education, and BMI